Since a wide variety of heterogeneity was found in tissue mast cells, recent studies have focused on the process of differentiation and maturation of mast cells. It has been largely accepted that the ability of histamine synthesis is high in the mucosal type mast cells whereas that is low in the tissue-connective type mast cells, although it remains largely unknown how histamine synthesis is regulated during differentiation. Interleukin (IL)-4 is one of the candidate factors that regulate the process of mast cell differentiation. We investigated the effects of IL-4 on histamine synthesis using a murine IL-3-dependent mucosal-type mast cell line, BNu-2cl3. IL-4 drastically suppressed histamine synthesis at the transcriptional levels. Storage of histamine was significantly decreased upon prolonged treatment with IL-4. Down-regulation in expression of histidine decarboxylase by IL-4 was restored by addition of excessive amount of IL-3. Changes in mRNA expression of mouse mast cell proteases (MMCPs) in the cells treated with IL-4 mimicked the differentiation process from mucosal-type to connective tissue-type mast cells; mRNA expression of MMCP2 was decreased, whereas that of MMCP4 and carboxypeptidase A3 were unchanged. These results suggest that IL-4 should play a critical role in suppression of histamine synthesis in mucosal-type mast cells.
Mast cells are involved in a wide variety of immune responses including immediate type allergy through release of a series of paracrine mediators, such as histamine, arachidonic acid metabolites, and cytokines. 1) Mast cells originate in hematopoietic stem cells in the bone marrow and differentiate into mature mast cells in the tissues, in which they ultimately reside.
2) Accumulating evidences suggest that differentiation and maturation of mast cells are regulated by several cytokines, such as stem cell factor (SCF), interleukin (IL)-3, and IL-4. [3] [4] [5] Murine mast cells have been roughly classified into two categories based on functional expressions; connective tissue type mast cells store a large amount of highly sulfated proteoglycans, such as heparan sulfate, and have potentials to degranulate in response to cationic secretagogues, whereas mucosal mast cells do not. 1) This conventional classification also indicates that the enzyme activity of histidine decarboxylase (HDC), which is the rate-limiting enzyme for histamine synthesis, is much lower in connective tissue type mast cells than in mucosal mast cells.
1) It remains largely unknown how histamine synthesis is regulated during differentiation and maturation of mast cells.
IL-4 is a pleiotropic cytokine produced by T cells, mast cells, and basophils. [6] [7] [8] IL-4 is one of the primary cytokines that drive the T helper (Th)2 responses and induces IgE production by B cells. 9) Regarding regulation of mast cells, IL-4 was found to promote proliferation and differentiation in cooperation with IL-3 and/or SCF. [10] [11] [12] In contrast, other studies demonstrated the negative effects of IL-4 on mast cells; IL-4 suppresses expression of the high affinity IgE receptor (FceRI) and c-kit, and induces apoptosis in combination with IL-10. [13] [14] [15] Since IL-4 was found to have a potential to induce differentiation of mast cells toward connective tissue type mast cells, 10, 11) it is possible that IL-4 is involved in down-regulation of HDC in the connective tissue type mast cells. In the current study, we investigated the effects of IL-4 on histamine synthesis using an mucosal type-like mast cell line, BNu-2cl3.
MATERIALS AND METHODS
Cell Culture An IL-3-dependent mast cell line, BNu2cl3, which was established from splenocytes of Balb/c mice, 16) was cultured in RPMI-1640 medium containing 10% heat-inactivated FCS and 10% WEHI-3 conditioned medium as a source of IL-3, at 37°C in a fully humidified 5% CO 2 atmosphere. WEHI-3 conditioned medium prepared in this study contained 1-2 ng/ml of IL-3.
Materials IL-3, IL-4, IL-9, IL-10, IL-13, SCF, and interferon (IFN)-g were obtained from R&D Systems (Minneapolis, MN, U.S.A.). All other chemicals were commercial products of reagent grade.
Histamine Assay Cells were homogenized in 10 mM HEPES-NaOH, pH 7.3 containing 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol, 1 mM EDTA, 1 mM EGTA, 0.1 mM benzamidine, 0.2 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 10 mg/ml E-64, 1 mg/ml pepstatin A. The homogenate was centrifuged at 100000ϫg for 1 h at 4°C and the resultant supernatant was subjected to the enzyme assay. HDC activity and histamine was measured as described previously.
17)
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Total RNAs were extracted from BNu-2cl3 cells. Reverse transcription reaction was performed using MMLV reverse transcriptase (New England Biolabs, Beverly, MA, U.S.A.) in the presence of random hexamers. The PCR reaction was performed with Taq DNA polymerase (TOYO-BO, Tokyo, Japan) using the first strand as a template. The primer pair used for amplification of the transcripts was as follows; Hdc (forward) 5Ј-CGC TCC ATT AAG CTG TGG TTT GTG ATT CGG-3Ј, and (reverse) 5Ј-AGA CTG GCT
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Norio SATO, a Satoshi TANAKA,* ,b,c Junji MATSUURA, a , Yuhji TAKASU, a and Atsushi ICHIKAWA CCT GGC TGC TTG ATG ATC TTC-3Ј; Mcpt2 (forward) 5Ј-AAC GGT TCG AAG GAG AGG TGT-3Ј, and (reverse) 5Ј-CCA GGG CAG GTA ATA GGA GAT-3Ј; Mcpt4 (forward) 5Ј-ACC ACA TTC TCG CCC TTA CAT-3Ј, and (reverse) 5Ј-TCT CAG TTT CAC CTC CCT CAG-3Ј; Cpa3 (forward) 5Ј-CAG GCA GGC ACA GTT ATG CAA-3Ј, and (reverse) 5Ј-AAC CCA GTC TAA GGA AGA GCC-3Ј; Gapdh (forward) 5Ј-TGA AGG TCG GTG TGA ACG GAT TTG GC-3Ј and (reverse) 5Ј-CAT GTA GGC CAT GAG GTC CAC-3Ј.
RESULTS

Suppression of Histamine Synthesis upon Treatment with IL-4
We investigated the effects of a series of cytokines (IL-4, IL-9, IL-10, IL-13, SCF, and IFN-g), which have been reported to affect growth and function of mast cells, on mRNA expression of HDC. Only treatment with IL-4 suppressed mRNA expression of HDC in BNu-2cl3 cells (Fig. 1A) . IL-4 suppressed the enzyme activity of HDC in a concentration dependent manner and the maximum inhibition was obtained in the presence of 10 ng/ml of IL-4 (Fig.  1B) . The time course analyses revealed that the enzyme activity was reduced by approximately 80% during 24 h-ofincubation (Fig. 1C) . Suppression of histamine synthesis was accompanied by decrease in histamine storage. Cellular histamine content was reduced by approximately 50% during 24 h-of-incubation. Prolonged culture in the presence of 10 ng/ml of IL-4 for 7 d resulted in complete depletion of cellular histamine (data not shown).
Restoration of Histamine Synthesis in the Presence of IL-3 IL-3 was found to induce mRNA expression of HDC in hematopoietic progenitors and immature basophils. 18, 19) We then investigated the effects of IL-3 on HDC activity in the cells treated with IL-4. Treatment of the IL-4-treated cells with IL-3 restored the enzyme activity, whereas prolonged treatment with IL-4 further reduced it (Fig. 2) . Simultaneously added IL-3 (30 ng/ml) was found to attenuate the inhibitory effects of IL-4 (data not shown).
Effects of IL-4 on Expression of Mouse Mast Cell Proteases
Expression profiles of mast cell proteases (MMCPs) have been studied as an index of mast cell differentiation. 20) We investigated mRNA expression of MMCPs such as MMCP2, MMCP4, and carboxypeptidase A3 (CPA3, mast cell carboxypeptidase A). Expression of MMCP2 was attenuated in the presence of IL-4, whereas those of MMCP4 and CPA3 were unchanged (Fig. 3) . Down-regulation in mRNA expression of MMCP2 was paralleled with that of HDC. These results suggest that changes observed in the cells treated with IL-4 partially reflect those during differentiation of mast cells, since expression of MMCP2 is characteristic of mucosal mast cells.
DISCUSSION
We demonstrated that histamine synthesis in an murine IL-3-dependent mast cell line, BNu-2cl3, was inhibited by IL-4 through suppression of mRNA expression of HDC. Further- 10) a series of studies forms a contrast to their results; no significant levels of histamine synthesis was observed in their bone marrow culture in the presence of SCF, whereas SCF-mediated induction of histamine synthesis has been reported in various kinds of mast cell models, such as murine BMMCs, rat peritoneal mast cells, and murine pulmonary mast cells. [21] [22] [23] In addition, since they did not investigate the effects of IL-4 in the absence of SCF, it remains unknown whether IL-4 alone has a potential to induce histamine synthesis in their culture system. Nabeshima et al. recently demonstrated that histamine storage was increased in murine BMMCs co-cultured with a fibroblastic cell line in the presence of They also demonstrated that histamine content in BMMCs was decreased under the condition, in which IL-4-induced signal transduction in the fibroblasts was disturbed by forced expression of the dominant negative form of signal transducer and activator of transcription (STAT) 6. Thus they concluded that IL-4 might accelerate histamine synthesis in BMMCs in an indirect manner via a factor(s) derived from fibroblasts. In contrast to these previous reports, our findings suggest that IL-4 alone has a negative effect on expression of HDC in a murine cultured mast cell model.
Accumulating evidence suggests that IL-4 has positive and negative effects on mast cell function. This inconsistency could be attributed at least in part to heterogeneity of mast cell populations. Although mast cells are regarded to undergo terminal differentiation and maturation in the tissues, into which they are infiltrated, we have no suitable model culture systems for analysis of such processes. IL-4-mediated responses may vary in the context of tissue distribution and maturation of mast cells. Indeed, histamine content of peritoneal mast cells from IL-4 deficient mice was comparable to that from the wild-type mice. 25) We observed no significant changes in histamine synthesis in murine BMMCs in the presence of IL-4 (data not shown). BMMCs are regarded as a model of immature mast cells, since they can differentiate into either connective tissue-type mast cells or mucosal-type mast cells depending on microenvironmental conditions. 2) Previous studies demonstrated that mucosal mast cell-specific proteases, such as MMCP1 and MMCP2, were induced in BMMCs treated with IL-10. 26, 27) Our results that MMCP2 was expressed in BNu-2cl3 under steady state conditions suggest that BNu-2cl3 reflects characteristics of mucosal mast cells. Suppressive effects of IL-4 may be observed exclusively in mucosal-type mast cells. Further analyses should be required to determine the conditions, under which IL-4 can inhibit histamine synthesis in mast cells.
We observed that IL-4-mediated inhibition of histamine synthesis was counteracted by IL-3. The balance between IL-3 and IL-4 may play an important role in histamine synthesis in certain Th2-biased immune responses, such as parasite infection. It is generally regarded that the Th2 response has a tendency to form a positive feedback circuit; IL-4 enhances the Th2 population itself and production of IgE, and IgE is involved in antigen-dependent activation of mast cells, in which mast cells produce IL-4 in addition to the other cytokines. IL-4-mediated suppression of mast cell function may be involved in feedback regulation of Th2-biased immune responses.
